Dashboard
Manage Tickers

CINTCI&T Inc

NYSE ciandt.com


$ 4.88 $ 0.13 (2.73 %)    

Friday, 14-Jun-2024 15:58:16 EDT
CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ $ 479.30 $ 2.47 (0.52 %)
DIA $ 386.46 $ -0.42 (-0.11 %)
SPY $ 542.65 $ 0.33 (0.06 %)
TLT $ 94.67 $ 0.79 (0.84 %)
GLD $ 215.76 $ 2.76 (1.3 %)
$ 4.89
$ 4.99
$ 0.00 x 0
$ 0.00 x 0
$ 4.81 - $ 5.00
$ 3.34 - $ 7.20
123,429
na
104.48M
$ 1.58
$ 3.82
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
No Data found
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

perion-network-cuts-revenue-outlook-joins-skye-bioscience-and-other-big-stocks-moving-lower-in-mondays-pre-market-session
Perion Network Cuts Revenue Outlook, Joins...
06/10/2024 12:10:17

12-information-technology-stocks-moving-in-mondays-pre-market-session
12 Information Technology Stocks Moving In...
06/10/2024 12:06:11

12-information-technology-stocks-moving-in-fridays-intraday-session
12 Information Technology Stocks Moving In...
05/24/2024 16:30:52

deckers-outdoor-posts-upbeat-earnings-joins-guardant-health-ross-stores-and-other-big-stocks-moving-higher-on-friday
Deckers Outdoor Posts Upbeat Earnings, Joi...
05/24/2024 14:12:17

wedbush-initiates-coverage-on-cit-with-outperform-rating-announces-price-target-of-5
Wedbush Initiates Coverage On CI&T with Ou...
05/24/2024 12:04:02

Wedbush analyst Moshe Katri initiates coverage on CI&T (NYSE:CINT) with a Outperform rating and announces Price Target o...

elf-beauty-posts-upbeat-earnings-joins-nvidia-liveramp-holdings-borr-drilling-and-other-big-stocks-moving-higher-on-thursday
e.l.f. Beauty Posts Upbeat Earnings, Joins...
05/23/2024 14:26:28

canaccord-genuity-upgrades-cit-to-buy-raises-price-target-to-6
Canaccord Genuity Upgrades CI&T to Buy, Ra...
05/23/2024 11:56:23

Canaccord Genuity analyst Joseph Vafi upgrades CI&T (NYSE:CINT) from Hold to Buy and raises the price target from $5 to $6.

cit-expects-fy24-net-revenue-growth-at-constant-currency-of--25-to-25-yy
CI&T Expects FY24 Net Revenue Growth At Co...
05/22/2024 11:30:01

cit-expects-q2-net-revenue-to-be-at-least-r542m-on-reported-basis-equivalent-to-35-growth-qq
CI&T Expects Q2 Net Revenue To Be At Least...
05/22/2024 11:29:16

cit-q1-adj-006-beats-005-estimate-sales-10576m-beat-10213m-estimate
CI&T Q1 Adj $0.06 Beats $0.05 Estimate, Sa...
05/22/2024 11:11:42

CI&T (NYSE:CINT) reported quarterly earnings of $0.06 per share which beat the analyst consensus estimate of $0.05 by 22 pe...

deep-dive-into-cit-stock-analyst-perspectives-4-ratings
Deep Dive Into CI&T Stock: Analyst Perspec...
05/14/2024 17:01:42

ubs-initiates-coverage-on-cit-with-neutral-rating-announces-price-target-of-42
UBS Initiates Coverage On CI&T with Neutra...
05/14/2024 14:05:46

UBS analyst Leonardo Olmos initiates coverage on CI&T (NYSE:CINT) with a Neutral rating and announces Price Target of $4.2.

citigroup-maintains-neutral-on-cit-lowers-price-target-to-425
Citigroup Maintains Neutral on CI&T, Lower...
04/22/2024 15:40:32

Citigroup analyst Ashwin Shirvaikar maintains CI&T (NYSE:CINT) with a Neutral and lowers the price target from $4.5 to $...

bw-gesto-de-investimentos-reported-passive-stake-of-94-in-cit-class-a-common-stock-as-of-april-3-2024-in-13g-filing
BW Gestão De Investimentos Reported Passiv...
04/15/2024 20:56:17

canaccord-genuity-maintains-hold-on-cit-raises-price-target-to-5
Canaccord Genuity Maintains Hold on CI&T, ...
03/18/2024 11:07:22

Canaccord Genuity analyst Joseph Vafi maintains CI&T (NYSE:CINT) with a Hold and raises the price target from $4 to $5.

cit-inc-says-for-fy24-expect-net-revenue-growth-at-constant-currency-to-be-in-the-range-of--25-to-25-yoy
CI&T Inc Says For FY24, Expect Net Revenue...
03/14/2024 12:02:40

canaccord-genuity-maintains-hold-on-cit-lowers-price-target-to-4
Canaccord Genuity Maintains Hold on CI&T, ...
03/08/2024 17:11:50

Canaccord Genuity analyst Joseph Vafi maintains CI&T (NYSE:CINT) with a Hold and lowers the price target from $5.5 to $4.

cit-expects-q1-net-revenue-of-at-least-104m-vs-10678m-est-and-fy24-net-revenue-growth-of-25-25-vs-46108m-est
CI&T Expects Q1 Net Revenue of At Least $1...
03/07/2024 11:55:52

Business Outlook We expect our net revenue in the first quarter of 2024 to be at least R$520 million on a reported basis, assu...

cit-reported-prelim-q4-revenue-of-1055m-vs-1061m-est
CI&T Reported Prelim Q4 Revenue of $105.5M...
03/07/2024 11:52:04

Unaudited Fourth Quarter 2023 Results Net Revenue was R$ 522.6 million compared to R$ 611.8 million in 4Q22. Adjusted EBITD...

earnings-scheduled-for-march-7-2024
Earnings Scheduled For March 7, 2024
03/07/2024 09:49:44

Companies Reporting Before The Bell • CI&T (NYSE:CINT) is estimated to report quarterly earnings at $0.06 per share on rev...

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

06/28/2024 Malibu Boats, Inc. (MBUU)
07/01/2024 Globe Life Inc. f/k/a Torchmark Corporation (GL)
07/01/2024 Equinix, Inc. (EQIX)
07/02/2024 Intel Corporation (INTC)
07/05/2024 AXT, Inc. (AXTI)
07/05/2024 Altimmune, Inc. (ALT)
07/09/2024 Li Auto Inc. (LI)
07/12/2024 Inari Medical, Inc. (NARI)
07/12/2024 Sprout Social, Inc. (SPT)
07/15/2024 UnitedHealth Group Inc. (UNH)

NEW CASE INVESTIGATION

AnaptysBio Inc (ANAB)